Search Results Search Sort by RelevanceMost Recent State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Policy Forum Mar 2018 Who Counts? What Counts? Place and the Limits of Perinatal Mortality Measures Claire Wendland, MD, PhD Perinatal mortality indicators like the maternal mortality ratio mask social determinants of health and undermine reproductive justice. AMA J Ethics. 2018;20(3):278-287. doi: 10.1001/journalofethics.2018.20.3.pfor2-1803. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612. Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Policy Forum Mar 2018 Who Counts? What Counts? Place and the Limits of Perinatal Mortality Measures Claire Wendland, MD, PhD Perinatal mortality indicators like the maternal mortality ratio mask social determinants of health and undermine reproductive justice. AMA J Ethics. 2018;20(3):278-287. doi: 10.1001/journalofethics.2018.20.3.pfor2-1803.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.
Medicine and Society Dec 2016 Manipulating Memories: The Ethics of Yesterday’s Science Fiction and Today’s Reality Julie M. Robillard, PhD and Judy Illes, PhD Neuromodulation has ethical implications for self-identity and public communication of scientific findings. AMA J Ethics. 2016;18(12):1225-1231. doi: 10.1001/journalofethics.2016.18.12.msoc1-1612.
Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.